Cancer cells develop this angiogenic capacity via an “angiogenic switch” triggered by the synthesis and delivery of different positive signals that encourage angiogenesis, such as vascular endothelial growth factor (VEGF) that binds to the VEGF receptor (VEGFR) located on endothelial cells. The gene discussed is VEGFA; the disease is cancer.